Episodios
-
In this episode, Sandy Vance interviews Parminder âParryâ Bhatia, Chief AI Officer at GE Healthcare, about the integration of generative AI and machine learning in healthcare. They discuss the transformative potential of these technologies in improving clinical efficiency, reducing burnout, and enhancing patient care. Parminder shares insights on recent innovations, the concept of agentic AI, and the importance of responsible AI practices in ensuring safe and effective healthcare solutions. The discussion highlights GE Healthcare's commitment to advancing AI technologies while maintaining a focus on ethical considerations and collaboration with clinical partners.
In this Episode they discuss:
GE Healthcare is leading in AI and machine learning integration.Generative AI is set to revolutionize healthcare data management.AI technologies can significantly reduce clinical burnout.The Care Intellect application enhances oncology care efficiency.Agentic AI offers proactive solutions in complex healthcare scenarios.Responsible AI practices are crucial for building trust in technology.AI can streamline workflows and improve patient experiences.Collaboration with clinical partners is essential for innovation.The AI Innovation Lab fosters early-stage research and development.GE Healthcare aims to enhance healthcare delivery for over a billion patients.About Parminder "Parry" Bhatia:
At GE HealthCare, Parminder is focused on integrating AI across areas including smart devices, across the patient journey, and at the hospital operation level.
GE HealthCare has a long track record innovating in AI, and has topped the Food and Drug Administrationâs (FDA) list of AI-enabled medica devices for three years in a row, with 80+ AI-enabled medical device authorizations. Parminder leads a team that is helping to advance AI integration within medical devices at GE HealthCare, with the ultimate goal of enhancing patient outcomes and creating a world where healthcare has no limits. Parry is part of the companyâs internal committee on responsible AI to help ensure that new AI applications are reliable, scalable, and ethically sound. He has been recognized by the AIM âAI 100â 2024 Awards and Constellation Research's Artificial Intelligence 150 âAI 150â list.
Previously, Parminder was Head of Science for Generative AI at Amazon, where he led the development of machine learning and generative AI products including Amazon Comprehend Medical for analyzing medical record data at scale, Amazon Q for developer productivity, and Amazon Bedrock for democratizing access to Large Language Model technologies globally.
He has held previous roles in AI and machine learning at Microsoft and Georgia Tech.
-
About Hamilton Bennett:
Hamilton Bennett is a seasoned public health professional with over 15 years of experience, currently serving as the Senior Director of Vaccine Access and Partnerships at Moderna. She played a pivotal role in leading the mRNA-1273 COVID-19 vaccine development program, contributing significantly to one of the earliest and most effective vaccines against the pandemic. With a strong dedication to equitable vaccine development and distribution, Hamilton collaborates closely with governments and stakeholders to build resilient health systems capable of responding swiftly to pandemics and vaccine-preventable diseases.
Hamilton is passionate about fostering innovation through Moderna's "mRNA Access Program," which enables academic researchers to use Moderna's platform to improve emergency disease responsiveness. Her educational background includes graduate degrees in Environmental Health and Microbiology from the University of Washington, along with a certificate in Epidemiology from the London School of Hygiene and Tropical Medicine. Hamilton's commitment to cutting-edge research and global health equity continues to drive her efforts in transforming the vaccine landscape.
Things Youâll Learn:
Moderna's innovative mRNA technology has the potential to revolutionize the vaccine landscape.The importance of equitable vaccine development and distribution to ensure all communities have access to life-saving vaccines.Collaboration with governments and stakeholders is crucial for building resilient health systems capable of responding to pandemics and vaccine-preventable diseases.Moderna's mRNA Access Program enables academic researchers to use their platform, fostering innovation and improving emergency disease responsiveness.The necessity of strategizing for both current healthcare needs and future challenges, emphasizing the importance of collaboration, cutting-edge research, and global health equity.Resources:
Connect with and follow Hamilton Bennett on LinkedIn.Follow Moderna on LinkedIn and visit their website. -
¿Faltan episodios?
-
About Allison Stalla:
Allison Stalla is a distinguished leader in the realm of healthcare technology, currently holding the position of Director of Clinical Applications at Microsoft Cloud for Healthcare. With a robust focus on reducing the documentation burdens faced by nursing clinicians, Allison utilizes cutting-edge AI technologies to enhance patient care and mitigate nurse burnout. Her comprehensive background includes significant contributions at Nuance Communications as the Principal of Client Insights, where she influenced healthcare strategy and client engagement. Allison is dedicated to advancing clinical applications that prioritize user-centric design, integrating AI into healthcare workflows, and driving digital transformation in healthcare settings.
In her role at Microsoft, Allison emphasizes the importance of change management and data literacy for successful AI adoption in healthcare. She is deeply committed to fostering a collaborative environment where healthcare professionals can thrive. Her efforts are particularly concentrated on creating nurse-centered technologies, ensuring that the tools developed are not only innovative but also practical and beneficial for everyday clinical use. Through strategic partnerships and pilot programs, Allison's work at Microsoft continues to push the boundaries of what's possible in healthcare technology, ultimately aiming to improve patient outcomes and streamline clinical processes.
Things Youâll Learn:
AI is significantly reducing documentation burdens for nurses, allowing them to focus more on patient care and reducing burnout.Despite concerns about AI replacing jobs, there's broad willingness across various age groups to adopt AI in nursing.Successful AI adoption in healthcare requires strong leadership support, effective change management, and enhanced data literacy among healthcare professionals.Involving nurses in the development and design process of AI tools is crucial for building trust and ensuring these tools meet their needs.Microsoft's collaboration with Nuance and nine development partners focuses on creating nurse-centered technologies, including piloting ambient voice technology to aid bedside documentation.Resources:
Connect with and follow Allison Stalla on LinkedIn.Follow Microsoft on LinkedIn.Visit the Microsoft Cloud for Healthcare website and check out their blogs. -
In this episode of AI @ HLTH on The Beat, Sandy Vance speaks with Dr. Benjamin Nguyen from Transcarent about the innovative Wayfinding platform, which integrates AI to enhance healthcare navigation for employees. They discuss the challenges of healthcare engagement, the importance of personalized experiences, and the role of AI and LLMs in transforming healthcare delivery. Dr. Nguyen emphasizes the need for privacy and security in healthcare AI solutions and shares insights on the future of AI in the industry.
In this Episode they discuss:
Employees deserve benefits that empower them with guidance.Transcarent aims to simplify healthcare navigation.Wayfinding connects various healthcare solutions in one platform.Healthcare complexity leads to disengagement among employees.AI can provide personalized healthcare experiences.LLMs enhance engagement by tailoring responses to individuals.Privacy and security are paramount in healthcare AI.Transcarent does not train LLMs on customer data.The future of healthcare will see more subtle AI integration.Investing in innovative solutions is key for employers.A little about Dr. Benjamin Nguyen:
Dr. Benjamin (Ben) Nguyen, M.D. is a healthcare and AI product leader. At Transcarent, Dr. Nguyen currently leads the Transcarent AI team which is tasked with expanding Transcarentâs suite of AI products while maintaining the highest standards for patient safety. Throughout his career, Dr. Nguyen has led multiple teams building AI products ranging from hospital AI deployment platforms, radiology AI safety applications, chatbots for patients, and AI tools for clinicians. Dr. Nguyen is known as an expert on AI in healthcare, and was recently called to testify before Congress on the subject, educating lawmakers and the public about the potential and safety risks of AI. He is also a guest lecturer at the University of Southern California, where he teaches about AI fundamentals and safety in healthcare. Dr. Nguyen received his Doctor of Medicine degree at the Keck School of Medicine of USC, as well as graduate specialization certificates from the Marshall School of Business and the Viterbi School of Engineering. He is a Bay Area native and lives in San Francisco, California.
-
About Paul Markovich:
Paul Markovich is the president and CEO of Blue Shield of California, a nonprofit health plan generating $24 billion in annual revenue and serving 4.8 million members across various markets in California. With over 25 years of experience at Blue Shield, Paul has driven numerous innovative initiatives, including funding a statewide provider directory, supporting the development of a statewide health information network for holistic patient care, and partnering with the California Medical Association to pilot new care delivery models. His leadership focuses on reimagining healthcare by leveraging technology and creating a system that is both affordable and high-quality.
Previously, Paul served as the chief operating officer, overseeing crucial areas such as healthcare services, network management, marketing, and customer operations. He has a history of introducing groundbreaking products and services, including the first California Health Maintenance Organization to allow self-referrals to specialists and online access to member benefits. Paul serves on the boards of the Blue Cross Blue Shield Association and Americaâs Health Insurance Plans. A North Dakota native and Rhodes Scholar, he holds a master's degree in philosophy, politics, and economics from Oxford University and a Bachelor of Arts in International Political Economy from Colorado College, where he also played Division I hockey.
Things Youâll Learn:
Blue Shield of California's collaboration with Salesforce aims to digitize the prior authorization process, making it as seamless as credit card transactions and eliminating the need for outdated fax machines.Rather than making incremental improvements, Blue Shield focuses on creating a new, functional healthcare system with comprehensive digital health records.Successful healthcare innovation requires strong collaborations, as exemplified by the partnership with Salesforce for real-time data integration.Paul emphasizes the importance of learning from failures and aligning with skilled partners to drive meaningful innovations.Blue Shield's nonprofit mission centers on providing affordable, stress-free healthcare access and improving patient care through advanced digital solutions.Resources:
Connect with and follow Paul Markovich on LinkedIn.Follow Blue Shield of California on LinkedIn and visit their website -
In this episode, host Sandy Vance talks with Bill Miller, CEO of WellSky, about the evolving role of analytics in healthcare and its impact on patient care. Bill emphasizes that the healthcare industry must invest in AI solutions to tackle pressing challenges, such as the home-based care staffing crisis, reducing clinician "pajama time," ensuring smoother transitions from hospital to post-acute care and streamlining workflows within existing electronic health record systems. These advancements will enable clinicians to focus on what truly mattersâproviding human-centered care. Bill also discusses WellSky's collaboration with Google to develop AI tools designed to support, not replace, clinicians.
In this episode, they talk about:What WellSky does for the healthcare industry, specifically in direct careHow WellSky helps clinicians deliver optimal patient careWellSky's balanced approach to AI in healthcareThe importance of proactive versus reactive strategiesSupporting clients in and out of hospital settingsAccelerating the referral process with AI solutionsThe rationale behind WellSkyâs partnership with GoogleThe future of WellSky and AI in healthcareA Little About Bill:Bill Miller is the CEO of WellSky and a recognized leader in the healthcare industry. He has a rich background including more than 25 years of groundbreaking growth strategies and technological innovation in the healthcare marketplace and a proven track record of launching and leading highly successful healthcare IT companies. Under Billâs leadership, WellSky has become one of Americaâs largest and most innovative healthcare technology companies, serving more than 20,000 clients across acute, post-acute, and community care.
He has overseen the strategic acquisition of more than 14 companies to the WellSky portfolio, helped establish the WellSky Foundation, and guided the company into new marketplaces with innovative technology and services shaping the industry. Before joining WellSky in 2017, Bill served as the CEO of OptumInsight, a division of Optum, which is the health services platform of UnitedHealth Group. Under Billâs direction, OptumInsight experienced unprecedented revenue growth, expanded margins, and claimed a transformative position in the health services market.
He led the evolution of Optum into the leader in healthcare analytics and launched several tech-enabled business platforms. Before OptumInsight, Bill served as senior vice president of technologies at Cerner Corporation, where he had global responsibility for the companyâs managed services, outsourcing, and technology services business units. Bill currently sits on the board of directors for Lyric and Lifestance, both in the healthcare sector and the WellSky Foundation. A graduate of the University of Kansas, Bill earned his bachelorâs degree in economics and a masterâs degree in urban planning and public policy. He enjoys spending time with his three children Ellie, 24, Belle, 21, and Matthew, 20.
-
Host Sandy Vance is behind the mic in this episode with Chris Chang, CEO and Co-Founder at GradientAI. Have any questions for Chris? Reach out via email or check out their website.
They explore why GradientAI focuses specifically on the healthcare industry and how its innovative solutions are enhancing patient care and operational efficiency. They also address common concerns surrounding AI adoption and share exciting use cases and future developments. Listen in as Sandy and Chris navigate the intersection of GradientAI and AI in healthcare, revealing the potential to reshape the future of medicine.
GradientAI enables enterprises to automate their complex data workflows using its AI-powered data-reasoning platform. They work with many integrated care providers and health tech companies to power processes across the organization, from medical note auditing to the improvement of care to patients, benefit management, claims processing, and data reconciliation.Enterprise AI automation in healthcare, powered by Nightingale - a domain-specific model designed specifically for healthcare.
In this episode, they talk about:Why GradientAI Focuses on Healthcare and the Benefits of AI in HealthcareHow GradientAI Helps the Healthcare IndustryPros and Cons of Workflow Tools That Limit Information in HealthcareThe Transformative Technology of AI in the Healthcare IndustryUse Cases, Trials, and Development of AI in HealthcareAddressing Concerns of Those Wary About AI in HealthcareThe Future of GradientAI and AI in HealthcareA Little About Chris:Chris is the Co-Founder and CEO at Gradient, who most recently led Studio AI at Netflix and was an architect of early domain expert LLMs for content production and intelligence. Prior to joining Netflix, Chris held a variety of leadership roles at Pinterest, Opendoor, and Meta. Chris started his career in finance and holds a dual bachelor's degree in computer science and business and a master's degree in computer science from UPenn.
-
In this conversation, Sandy Vance speaks with Pratap Khedkar, CEO of ZS, about the pressing issues in healthcare, particularly the scarcity of providers and the potential of AI to create healthcare abundance. They discuss the gaps in the current healthcare system, the global provider shortage, and the role of AI in addressing these challenges. Khedkar emphasizes the importance of trust in AI, the need for regulatory frameworks, and shares real-world use cases of AI improving patient care and clinical trials. The conversation concludes with a look ahead to ZS's vision for the future of healthcare and the integration of AI.
In This Episode, they talk about :
ZS aims to improve life through healthcare innovation.Healthcare gaps are widening, leading to patient dissatisfaction.AI can help bridge the gap between data and human capability.The US faces a significant shortage of healthcare providers.Trust in AI is a major barrier to its adoption in healthcare.AI can predict patient drop-off rates for medications.Regulatory frameworks are needed for AI in healthcare.Collaboration between public and private sectors is essential for AI standards.AI tools can enhance the patient experience and reduce burnout.The future of healthcare will involve a synergy between humans and AI.A little about Pratap:
Pratap was elected CEO of ZS in July 2021. Prior to this, he led the firmâs global pharmaceuticals practice for nine years, as well as a practice focused on the dynamics of healthcare ecosystems. He founded and led its advanced data science capability track, which focuses on AI.
-
In order to deep dive into these topics, Sandy chats with Tariq Khan from Reteta about the new possibilities for AI in improving care visibility and advancing diagnostics and therapeutics. Tariq talks about AI for clinical documentation and revenue management, AI in wearable sensors/digital biomarkers and digital therapeutics design (including validation studies), pharmacovigilance automation, and ai-driven EHR and real-world health data processing.
In this episode, they talk about:Reteta is an AI platform and app that integrates with EHR and automates patient charting and notesCare delivery processes and back office processesIn what ways can AI enhance patient outcomes while simultaneously lowering costsExamples of AI applications that have successfully improved care visibilityAI is pushing the boundaries of diagnostics and therapeutics in both healthcare and life sciencesThe role of AI will evolve in the next 5 years within these fieldsExamples of AI applications that have successfully improved care visibility and patient managementHow AI is pushing the boundaries of diagnostics and therapeutics in healthcare and life sciencesThe significant contributions of AI to advancing health equity in diverse populationsPredictions on how AI will evolve over the next five years in healthcare and life sciences.Case studies where AI has significantly transformed specific aspects of healthcare and life sciencesA Little About Tariq:Tariq Khan is an enterprise strategist for AI transformation working with C-suite clients to realize the re-invention of business using AI. He has cofounded GenAI product startups to lead the transformation of healthcare and life sciences from the front. He serves as the Chief Technology and Chief AI Officer at Reteta.
-
In this episode, host Sandy Vance is chatting with CTO & Co-Founder Mark Stoehr, and Jack Ryan, Chief Product Officer, both from XSELL, the leader in conversational AI for contact centers. Theyâre here to discuss their innovative eXpert Language Model (XLM), designed for real-time dialogue. They will explore the key challenges facing the industry, the benefits of AI in enhancing agent efficiency and customer satisfaction, and gain valuable insights into the future of AI in contact centers. Whether youâre a tech enthusiast or a healthcare professional, this conversation promises to shed light on how generative AI is reshaping the landscape.
In this episode, they talk about:XSELLâs Journey into the Healthcare SpaceThe Benefits of Generative AI's AdaptabilityFeedback, Reviews, and Use Cases for XSELLThe Role of AI in Contact CentersDelivering High Value to Organizations with Low InvestmentHow Insurance Companies Are Using and Considering Generative AIThe Importance of Respecting Domain ExpertsXSELLâs Vision for the Future of Generative AI in HealthcareA Little About Jack and Mark:Jack Ryan is Chief Product Officer at XSELL. Jack comes to XSELL from a job leading user-facing products at Google Meet, AWS (Amazon Connect), and Qualtrics. As a technical lead, Jack worked across engineering, product, and UX to drive innovation and deliver exceptional user experiences.
Mark Stoehr is the CTO and technical Co-Founder of XSELL Technologies. While he was pursuing PhD in Computer Science from University of Chicago, he met co-founder Matt Coughlin and developed the vision of an AI that is trained to replicate great performance by a company's agents. Prior to that, during his PhD program, he had spent some time working on Google Home and consulted for several start-ups.
If you want to reach out to XSELL with questions or comments, email their marketing team at [email protected]
-
In this episode, host Sandy Vance chats with Raleigh Murch (the Managing Director of AI for HCLS at NTT DATA) and Dr. John Frownfelter (the Healthcare Industry Consulting Director at NTT DATA).
Join Sandy, Raleigh, and John as they explore the evolution and future of NTT DATA in healthcare innovation, highlighting key promising areas for AI integration. The discussion will also cover how organizations can grow and mature in their AI awareness, the importance of establishing robust governance structures, and the ongoing concerns within the healthcare community regarding AI solutions.Raleigh and John also explain how NTT DATA is transforming healthcare and the importance of foundational processes when using GenAI. It will also showcase how we implement various GenAI solutions for our healthcare clients today. Discover more about NTT DATA's and GenAI's impact on Healthcare in this podcast at HLTH 2024. Don't miss this insightful conversation that could shape the future of healthcare!
In this episode, they talk about:The Evolution and Future of NTT DATA in Healthcare InnovationKey Promising Areas for AI Integration in HealthcareOrganizational Growth and Maturity in the Era of AI AwarenessEstablishing Governance Structures and Enhancing Data Maturity for HealthcareAddressing Concerns: The Healthcare Community's Hesitation Towards AI SolutionsA Little About Raleigh:Raleigh Murch is a Managing Director for AI supporting NTTDATAâs Healthcare and Life Sciences vertical. Raleigh led the Technology organization for Slalom for the South-Central Region and was a regional SME for GenAI. Before Slalom, Raleigh was a leader within AWSâs Global Specialty Practice for AI/ML with a deep focus on computer vision and edge IoT solutions. His past roles include being a Silicon Valley founder for a maritime engine analytics company, embedded hardware prototype consultant, and a long career in the industry as a product and engineering org leader. Raleigh has been working in emerging technologies for most of his career and works hands-on with company leaders to help define the art of the possible in the industry.
A Little About John:John Frownfelter, MD, FACP Healthcare Industry Consulting Director- Lead for Data-Driven Health, NTT DATA. Dr. Frownfelter brings more than 20 years of physician leadership experience to bear on the challenges in healthcare today. His HealthIT leadership roles in the c-suites of large provider organizations including Henry Ford Health, UnityPoint Health, and Trinity Health, are augmented by more recent work in consulting and with healthcare startups. He has a broad range of expertise in organizational care transformation, change management with health IT, strategic planning, and leveraging analytics to empower organizations at all levels. At NTT DATA Dr. Frownfelter is leading several initiatives including digital transformation through virtual care at home and Generative AI for healthcare.
-
In this episode, host Sandy Vance chats with Sharmin Nasrullah, the GM of Life Sciences Clinical. In this insightful conversation, they explore how AI and data are revolutionizing the landscape of clinical trials, paving the way for holistic and personalized approaches in the pharmaceutical industry. Tune in to discover the innovations shaping next-generation trials and how organizations are leveraging technology to enhance patient experiences and outcomes.
In this episode, they talk about:The birth of Salesforceâs Life Science Cloud platformWhat Salesforce is doing in the clinical trial spaceUnderstanding recruitment processes in clinical trialsHow Salesforce eases the research burdens for sponsors and sitesPatient information transfer from providers to Salesforce Life Science Cloud PlatformThe impact of AI advancements on the clinical trial processSystems replaced by Salesforceâs cloud applicationHow the cloud system matches patients with clinical trialsA Little About Sharmin:Sharmin Nasrullah is the GM of Life Sciences, Clinical at Salesforce. As General Manager, Sharmin leads the overall product strategy and go-to-market strategy for the R&D clinical suite of applications and products on Life Sciences Cloud, leveraging the best of the Salesforce platform and ushering in a new wave of innovations in clinical development.
Before Salesforce, Sharmin held several leadership positions across the industry including leading digital health enterprise architecture at AstraZeneca, leading product and sales strategy in clinical data management at Veeva Systems, and leading clinical operations at Stanford Universityâs academic research organization.
Sharmin holds a Master of Science in Bioengineering from Stanford University and a Bachelor of Science in Electrical Engineering from the University of Waterloo.
-
In this episode of The Beat Podcast, host Sandy Vance sits down with Sam Dorison, Co-Founder and CEO of ReflexAI, to explore the transformative role of AI technology in healthcare. From its origins at the Trevor Project to its groundbreaking applications today, ReflexAI is revolutionizing patient care through advanced AI-driven simulations. Join us as Sam delves into how ReflexAIâs innovative solutions are addressing critical challenges in the healthcare industry, enhancing patient support, and improving training environments. Discover the impact of ReflexAIâs technology and get an insiderâs look at how itâs shaping the future of healthcare.
ReflexAI helps maximize training and quality assurance platforms using AI in order to help cut costs and increase efficiency. You can email questions and reach out to Sam at [email protected].
In this episode, they talk about:The evolution of ReflexAI from its inception at the Trevor Project.How ReflexAI leverages AI technology to tackle challenges in the healthcare industry.Creating Healthcare Flight Simulator for front line cliniciansSpecific use cases where ReflexAIâs AI-driven simulations have been particularly impactful in healthcare settings.How ReflexAIâs AI-driven simulations enhance patient support and training across various healthcare environments.An overview of the mechanics behind ReflexAI and its impact on improving patient care.A Little About Sam:Sam Dorison is the Cofounder and Chief Executive Officer at ReflexAI. An expert in artificial intelligence strategy and product deployment, Dorison has been involved with AI-powered products in industries ranging from mental health to cybersecurity to smart cities.
Before launching ReflexAI, he served as Chief Strategy & Innovation Officer at The Trevor Project, the worldâs largest suicide prevention and crisis intervention organization for LGBTQ young people. There, he published five peer-reviewed articles on mental health and oversaw teams including crisis services, training, research, technology, and finance. Dorison previously worked at McKinsey & Company and Harvard Kennedy School. He graduated summa cum laude and Phi Beta Kappa from Princeton Universityâs School of Public and International Affairs. He also holds an LL.M. from Cambridge University and a masterâs degree from University College London, both as a Marshall Scholar. Beyond ReflexAI, Dorison is heavily involved in causes that support families impacted by cancer. Dorison lives in New York City with his husband.
-
In this episode, host Sandy Vance chats with Optomed Managing Director David Frasch about how AI can augment physicians' abilities and daily responsibilities in this space. Optomed is a handheld fundus camera manufacturer based in Finland and has been in operation for the last 20 years.
In this episode, David will shed light on how Optomed cameras harness the power of AI to enhance the diagnosis and management of diabetic retinopathy. They explore the development of cutting-edge algorithms for medical diagnostics, the challenges of creating clinical algorithms without standardization, and the broad applications of AI across the healthcare sector. Stay tuned for a fascinating discussion on the transformative impact of AI in healthcare!
In this episode, they talk about:How Optomed leverages AI to improve diagnosis and treatment of diabetic retinopathyDeveloping advanced algorithms for medical diagnosticsChallenges in creating optimal clinical algorithms without standardizationApplications of AI across various sectors in the healthcare industryAddressing ethical and privacy concerns in AI-driven healthcare solutionsEmerging trends in the application of AI in medicine and healthcareThe strategic partnership between AI Health and OptomedFuture collaborative opportunities between AI Health and physiciansA Little About David:With a decade of experience in medical sales within ophthalmology, David has recently excelled in building high-performance sales teams at BioTissue. As a director there, he successfully transformed the team's performance from worst to first, a process that was both challenging and rewarding. In his new role at Optomed, David aims to replicate this success by focusing on team development and growth. He is committed to growing the team in a controlled manner and laying a strong foundation for building a powerful and resilient organization.
-
Today, Host Sandy Vance is talking with Robert Dwyer, PhD EVP, Chief Data Scientist at Certilytics about AI and healthcare. Dr. Dwyer is here to help demystify and readiness of generative AI. They delve into the transformative impact of generative AI on healthcare data and its revolutionary potential for the industry. Join us as we explore Certilytics, a company dedicated to creating a user-friendly interface for interacting with healthcare data, and their role in empowering healthcare organizations to enhance their efficiency with AI.
AI's role in healthcare is now presenting new opportunities for healthcare data and analytics to go beyond just Large Language Models (LLMs) and deliver business intelligence that can impact healthcare administration strategies and help accelerate improved outcomes & efficiency in healthcare.
In this episode, they talk about:
Dr. Dwyerâs background in generative AI and his journey to CertilyticsHow generative AI is transforming the insights that healthcare leaders and organizations can derive from their dataThe impact of data availability on the use and effectiveness of AI in healthcareCertilyticsâ goal to develop a user-friendly interface that enhances how users interact with healthcare dataThe current surge in AI technology and its implications for the industryThe latest advancements and innovations in large language modelsThe influence of federal regulations on the adoption and application of AI in healthcareHow healthcare organizations are leveraging AI-enriched data to improve outcomes and efficiencyA Little About Dr. Robert Dwyer:Dr. Dwyer joined Certilytics in 2014, bringing over a decade of mathematical modeling and machine learning experience in both the private sector and academia, where he worked on problems ranging from the quantification of medical and financial risk to predictive genomics. He is responsible for overseeing the design and pathing of new ML/AI products. Dr. Dwyer graduated from the University of Virginia in 2009 with a B.S. in Biology. He then obtained his M.S. and Ph.D. in computational biology from Princeton University, where he developed variations of maximum entropy algorithms to predict three-dimensional protein folding patterns by mining genomic sequence data. Prior to Certilytics, he worked with a number of startups and think tanks to develop algorithms to predict student loan repayment rates and to track Defense Department allocations.
Do you have any questions for Robert Dwyer? Reach out by emailing him at [email protected].
-
About Ezra Melhman:
Ezra Melhman is a seasoned healthcare investor and business leader with a rich background in providing strategic guidance to hospitals, healthcare systems, and healthcare companies. He joined Health Enterprise Partners (HEP) in 2010, as a Managing Partner, bringing with him a wealth of experience in consulting and research services for the healthcare industry.
Before joining HEP, Ezra served as a Senior Analyst at the Advisory Board Company (NASDAQ: ABCO), where he offered best-practice consulting and research services to hospitals and health systems. Following his tenure at the Advisory Board Company, he further honed his expertise as a Senior Consultant at Booz Allen Hamilton, focusing on engagements in the provider space.
Currently, Ezra holds positions on the board of directors of several prominent healthcare companies, including The Intermed Group, Wildflower Health, Kno2, Proven Behavior Solutions, Family First Adolescent Services, and Aware Recovery Care. He has a proven track record of successful board engagements, having previously served on the boards of AxiaMed, Applied Pathways, CenterPointe Behavioral Health System, InDemand Interpreting, Jvion, and Twistle, all of which were acquired by leading healthcare entities.
In addition to his board roles, Ezra contributes to academia as a member of the faculty at Columbia Business School and serves on the Health Policy and Management Executive Council at Harvard School of Public Health. He holds a BA cum laude from Washington University in St. Louis and earned his MBA from Columbia Business School. With his extensive experience and dedication to advancing healthcare, Ezra continues to make significant contributions to the industry.
Things Youâll Learn:
Profitability is now being highly rewarded among healthcare companies.The focus is shifting towards essential technologies and services in the healthcare sector.Stable healthcare services companies are garnering more interest amidst market uncertainties.A surge in M&A activity is anticipated, driven by private equity firms and strategic buyers.Specialization in a specific area can differentiate oneself in the venture capital space.Resources:
Connect with and follow Ezra on LinkedIn.Learn more about Health Enterprise Partners on LinkedIn and their website. -
About Lynne Chou O'Keefe:
Lynne Chou OâKeefe is the Founder and Managing Partner of Define Ventures, an early stage venture capital firm focused on investing in digital health companies redefining healthcare. Define Ventures focuses on incubation, seed, Series A, and Series B-stage digital health startups (www.definevc.com). Lynne has partnered with entrepreneurs to help them build category-defining digital health companies, such as Livongo (NASDAQ: LVGO), HIMS (NASDAQ: HIMS), Unite Us, etc. Previous to Define Ventures, Lynneâs experience includes both healthcare operating, investing, and finance roles. Previously, she was a Senior Partner at Kleiner Perkins, focused on digital health and connected devices early-stage investing. Before joining Kleiner Perkins, Lynne worked at Abbott Vascular and Guidant in multiple roles, launching over ten product families in the US and internationally. Lynne was responsible for building the global commercial strategy and therapy development, as well as playing a key role in the clinical, reimbursement, and operational strategy for these therapies. Earlier in her career, Lynne worked at Apax Partners with a focus on software venture capital investing. In addition, Lynne worked at Goldman Sachs in the Mergers and Acquisitions group and worked on multiple multi-billion dollar acquisitions and sell-side transactions in various industries. Lynne has been named WSJâs Women in Venture Capital to Watch in 2020. Lynne earned a Bachelor of Science degree in Industrial Engineering from Stanford University and an M.B.A. from Harvard Business School.
Things Youâll Learn:
Define Ventures leverages a founder-centric approach to provide strategic insights and partnerships that empower their portfolio companies with an unfair advantage in the digital health market.With $800 million in AUM and partnerships with about 24 companies to date, Define Ventures has become a significant player in the Silicon Valley startup ecosystem, emphasizing strategic insights and a deep understanding of the healthcare industry.It is important to be a supportive and empathetic partner to founders. Define Ventures offers strategic insights and an 'unfair advantage' by leveraging partnerships with providers, payers, and employers to transform the industry and support founders on their journeys.The striking a balance between growth and profitability with portfolio companies and believes the next 48 months will be dynamic for healthcare ventures.Resources:
Connect with and follow Lynne on LinkedIn.Learn more about Define Ventures on their LinkedIn and website. -
About Scott Barclay:
Scott Barclay is a Managing Director at Insight Partners based in Palo Alto. His Computational Care thesis envisions the future of US and global healthcare built at the intersection of empathy and scalable technology. Scottâs early career traversed capital markets with Banc of America Securities in Europe and the US, The Boston Consulting Group, and CVS Health. At CVS and then after, Scott helped create and scale the nationâs e-prescribing ecosystem, running iScribe (acq Allscripts) and as Chief Strategy Officer of Surescripts. Prior to Insight, Scott built his investing career as a healthcare angel investor and advisor (NaviHealth, Doximity, Elation) and, from 2015 â 2020, as a Partner at DCVC, a world-class early-stage deep tech venture capital firm, where he was a director or observer on the Boards of companies like Carbon Health, Freenome, SafelyYou, and many others.
Things Youâll Learn:
The three big themes that are set to revolutionize healthcare investment.The art and science behind Insight Partners' long-term investment and operational support strategies.Navigating valuation adjustments in turbulent markets and fostering founder relationships.The investment wisdom in an era of market recalibrationâwhat it really takes to write the check.Sustainability and profitability: Scottâs forecast on public exits for health tech startups.Resources:
Connect with and follow Lynne on LinkedIn.Learn more about Insight Partners on their LinkedIn and website. -
About Ian Wijaya:
Ian Wijaya is the Co-Head of Lazardâs North America Healthcare practice. Ian joined Lazard in 2011 and co-founded the Firmâs healthcare services practice, with a focus on M&A, strategic advisory, and recapitalization advisory for managed care insurance payers, providers across the continuum of care (e.g., acute care hospitals, ambulatory surgery centers, post-acute care, etc.), PBMs, distributors, payor and provider services companies, HCIT, and digital health companies.
Ian is a member of Lazardâs Opinion Committee and the World Economic Forumâs Global Future Council on Healthcare, as well as a Corporate Leader on the Council on Foreign Relations.
Ian has advised on more than $250 billion of corporate finance transactions, including mergers and acquisitions, leveraged buyouts, financial restructurings and reorganizations, joint ventures, and other matters, and has advised on several of the largest and most transformative M&A transactions in healthcare, including three of the largest in recent history.
Prior to joining Lazard, Ian was an investment banker at Greenhill & Co. in New York, where he focused on healthcare M&A but also provided M&A advice to companies in the technology and retail sectors. Prior to Greenhill & Co., he worked in the Investment Banking Division of Goldman Sachs & Co. and the financial restructuring group of Houlihan Lokey in New York.
Ian has an M.B.A. in Finance and Strategy from Northwestern Universityâs Kellogg School of Management and a B.A. (cum laude) from Dartmouth College.
Things Youâll Learn:
The candid examination of market barriers and what it takes to finalize deals in turbulent times.The healthcare tech market demands investments in businesses with sustainable unit economics and the potential for operating leverage, promoting a balance between profit and growth.Strategic buyers and private equity are looking for healthcare services that can enhance supply chain visibility, manage costs efficiently, and improve patient outcomes through tech-enabled solutions.AI stands poised to revolutionize healthcare across several domains, with an emphasis on clinical decision support, population health management, and automation of administrative tasks.AI in healthcare will likely boom in 3 areas: clinical support, population health management, and operational automation.Resources:
Connect with and follow Ian Wijaya on LinkedIn.Learn more about Lazard on their LinkedIn and website. -
About Omkar Kulkarni:
Omkar P. Kulkarni is the first chief innovation officer at Childrenâs Hospital Los Angeles. In his role, Kulkarni is responsible for fostering innovation across Childrenâs Hospital Los Angeles's clinical and research enterprises â including launching an enterprise virtual care program, incubating and implementing new digital health tools and medical devices, and rallying communities inside and outside of the hospital to solve problems in the field of pediatrics â all with the goal of enhancing the experience and outcomes for the children and families Childrenâs Hospital Los Angeles serves. Kulkarni is also the founder and managing director of KidsX, a consortium-based digital health accelerator that is comprised of over fifteen leading pediatric hospitals from around the world.
Prior to joining Childrenâs Hospital Los Angeles, Kulkarni served as executive director of the Cedars-Sinai Accelerator powered by Techstars, where he helped build and launch the accelerator program. In that role, he evaluated over 3,000 healthcare start-ups and provided extensive mentoring, serving as the main liaison between the start-up community and Cedars-Sinai Medical Center. Kulkarni also led the performance improvement department at Cedars-Sinai for many years and has experience in financial process redesign at NewYork-Presbyterian Hospital. Kulkarni has a masterâs degree in public health and health care management from Columbia University and a bachelorâs degree in business administration from George Washington University.
Things Youâll Learn:
AI can predict patient no-shows and optimize scheduling, freeing up crucial appointment slots and ensuring resources are optimally allocated.Adopting new solutions not only streamlines processes but boosts staff engagement and patient satisfaction by refocusing skilled labor on patient care rather than auxiliary tasks.Beyond financial health, measuring access, clinical outcomes, and patient/family engagement provides a more comprehensive view of organizational success.The challenge of serving a diverse, multilingual patient population, many of whom are under the poverty line.How CHLA manages to provide top-tier clinical care, groundbreaking research, and education, all while "defying gravity" in the face of financial struggles.Resources:
Connect with and follow Omkar Kulkarni on LinkedIn.Learn more about Children's Hospital Los Angeles on their LinkedIn and website. - Mostrar más
